Monday, October 18, 2021

China's inhalable COVID vaccine may boost antibodies 300-fold

The study suggests a heterologous (mix-match vaccine regimen) prime-boost regimen to increase the breadth, intensity and duration of the immune response, more than a homogeneous (same vaccine regimen) booster shot,

from Zee News :Zee News - Health https://ift.tt/3BWbADa
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

India reports first known case of MYSM1-related bone marrow failure syndrome in child

Doctors have treated what is believed to be India’s first known case of MYSM1-related bone marrow failure syndrome, a very rare inherited d...